Genomics and pharmacogenomics in anticancer drug development and clinical response /
Genomics and pharmacogenomics in anticancer drug development and clinical response /
edited by Federico Innocenti.
- Totowa, NJ : Humana, c2008.
- xiv, 377 p. : ill. ; 27 cm.
- Cancer drug discovery and development .
- Cancer drug discovery and development. .
Includes bibliographical references and index.
Genomic experimental approaches in oncology -- Pharmacogenomics of toxicity and response of chemotherapy -- Pharmacogenomics in clinical drug development in oncology.
1588296466 (hbk. : alk. paper) 1603270884 (e-ISBN) 9781588296467 (hbk. : alk. paper) 9781603270885 (e-ISBN)
2008938265
GBA871787 bnb
014627855 Uk 101493871 DNLM
Antineoplastic agents--Development.
Cancer--Genetic aspects.
Cancer--Molecular aspects.
Drug development.
Genomics.
Pharmacogenomics.
Antineoplastic Agents.
Genomics.
Neoplasms--drug therapy.
Neoplasms--genetics.
Pharmacogenetics--methods.
RC271.G45 / G48-2008
616.99/4042
2009 A-696 QV 269 / G335 2008
Includes bibliographical references and index.
Genomic experimental approaches in oncology -- Pharmacogenomics of toxicity and response of chemotherapy -- Pharmacogenomics in clinical drug development in oncology.
1588296466 (hbk. : alk. paper) 1603270884 (e-ISBN) 9781588296467 (hbk. : alk. paper) 9781603270885 (e-ISBN)
2008938265
GBA871787 bnb
014627855 Uk 101493871 DNLM
Antineoplastic agents--Development.
Cancer--Genetic aspects.
Cancer--Molecular aspects.
Drug development.
Genomics.
Pharmacogenomics.
Antineoplastic Agents.
Genomics.
Neoplasms--drug therapy.
Neoplasms--genetics.
Pharmacogenetics--methods.
RC271.G45 / G48-2008
616.99/4042
2009 A-696 QV 269 / G335 2008